BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29447242)

  • 1. A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44.
    Niehrs A; Garcia-Beltran WF; Norman PJ; Watson GM; Hölzemer A; Chapel A; Richert L; Pommerening-Röser A; Körner C; Ozawa M; Martrus G; Rossjohn J; Lee JH; Berry R; Carrington M; Altfeld M
    Nat Immunol; 2019 Sep; 20(9):1129-1137. PubMed ID: 31358998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells.
    Padoan B; Casar C; Krause J; Schultheiss C; Baumdick ME; Niehrs A; Zecher BF; Pujantell M; Yuki Y; Martin M; Remmerswaal EBM; Dekker T; van der Bom-Baylon ND; Noble JA; Carrington M; Bemelman FJ; van Lier RAW; Binder M; Gagliani N; Bunders MJ; Altfeld M
    Cell Rep; 2024 Apr; 43(4):114089. PubMed ID: 38615318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity.
    Balsamo M; Scordamaglia F; Pietra G; Manzini C; Cantoni C; Boitano M; Queirolo P; Vermi W; Facchetti F; Moretta A; Moretta L; Mingari MC; Vitale M
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20847-52. PubMed ID: 19934056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.
    Pende D; Parolini S; Pessino A; Sivori S; Augugliaro R; Morelli L; Marcenaro E; Accame L; Malaspina A; Biassoni R; Bottino C; Moretta L; Moretta A
    J Exp Med; 1999 Nov; 190(10):1505-16. PubMed ID: 10562324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-mediated inhibition of natural cytotoxicity receptor recognition.
    Seidel E; Glasner A; Mandelboim O
    Cell Mol Life Sci; 2012 Dec; 69(23):3911-20. PubMed ID: 22547090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory receptor CD47 binding to plasma TSP1 suppresses NK-cell IFN-γ production via activating the JAK/STAT3 pathway during HIV infection.
    Lang B; Wang M; Zhang Z; Fu Y; Han X; Hu Q; Ding H; Shang H; Jiang Y
    J Transl Med; 2023 Nov; 21(1):869. PubMed ID: 38037074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-licensed IFNγ
    Sanmarco LM; Wheeler MA; Gutiérrez-Vázquez C; Polonio CM; Linnerbauer M; Pinho-Ribeiro FA; Li Z; Giovannoni F; Batterman KV; Scalisi G; Zandee SEJ; Heck ES; Alsuwailm M; Rosene DL; Becher B; Chiu IM; Prat A; Quintana FJ
    Nature; 2021 Feb; 590(7846):473-479. PubMed ID: 33408417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints.
    Shemesh A; Brusilovsky M; Kundu K; Ottolenghi A; Campbell KS; Porgador A
    Cancer Immunol Immunother; 2018 Dec; 67(12):1871-1883. PubMed ID: 29264698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gintonin upregulates cytokine production and expression of NKp30, NKp44 and NKp44 related to natural killer cell activity on immunosuppressive rat.
    Chen B; Vijayakumar A; Park C; Choi U; Nah SY; Kim JH
    J Ginseng Res; 2024 May; 48(3):341-345. PubMed ID: 38707639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIEZO1-mediated mechanosensing governs NK-cell killing efficiency and infiltration in three-dimensional matrices.
    Yanamandra AK; Zhang J; Montalvo G; Zhou X; Biedenweg D; Zhao R; Sharma S; Hoth M; Lautenschläger F; Otto O; Del Campo A; Qu B
    Eur J Immunol; 2024 Mar; 54(3):e2350693. PubMed ID: 38279603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
    Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
    Front Immunol; 2018; 9():150. PubMed ID: 29456538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homer1 promotes the conversion of A1 astrocytes to A2 astrocytes and improves the recovery of transgenic mice after intracerebral hemorrhage.
    Fei X; Dou YN; Wang L; Wu X; Huan Y; Wu S; He X; Lv W; Wei J; Fei Z
    J Neuroinflammation; 2022 Mar; 19(1):67. PubMed ID: 35287697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Lymphoid Cells in the Central Nervous System.
    Wang S; van de Pavert SA
    Front Immunol; 2022; 13():837250. PubMed ID: 35185929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Immunomodulatory Activity of a Selected Strain
    Shang J; Wan F; Zhao L; Meng X; Li B
    Front Microbiol; 2020; 11():2089. PubMed ID: 32983062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of natural killer cells in Parkinson's disease.
    Earls RH; Lee JK
    Exp Mol Med; 2020 Sep; 52(9):1517-1525. PubMed ID: 32973221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells.
    Bowen KE; Mathew SO; Borgmann K; Ghorpade A; Mathew PA
    PLoS One; 2018; 13(2):e0193008. PubMed ID: 29447242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.
    Parodi M; Favoreel H; Candiano G; Gaggero S; Sivori S; Mingari MC; Moretta L; Vitale M; Cantoni C
    Front Immunol; 2019; 10():719. PubMed ID: 31024551
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.